Intrathecal analgesia is used in refractory cancer pain because of drug sides effects or intractable pain. The aim of this approach is to improve pain management, and also to improve patient comfort. This study will assess patient discomfort symptoms before and after setting up intrathecal analgesia.
Descriptive multicenter study including patients with refractory cancer pain (unmanageable drug sides effects or intractable pain) who will receive intrathecal analgesia Patient discomfort symptoms will be evaluated before and after the beginning of intrathecal analgesia at 15, 30, 60 and 90 days. Moreover, the impact on patient close relatives and on return home will be assessed.
Study Type
OBSERVATIONAL
Enrollment
20
Uhmontpellier
Montpellier, France
Number Evaluation of Edmonton symptoms
Edmonton symptom assessment system
Time frame: up to 90 days after patient inclusion
Autonomy assessment score for activities of daily living
Autonomy assessment score for activities of daily living
Time frame: 1 day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.